2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
K

2020 ASCO Update on Advanced Melanoma: Is PD-1 + Ipilimumab Superior to Ipilimumab Alone in Patients Resistant to PD-1 Therapy?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Kevin Kim
By 2020 ASCO Virtual Direct™ Highlights FEATURING Kevin Kim
28 views
August 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Skin
18:34

2020 ASCO Update on Advanced Melanoma: Is PD-1 + Ipilimumab Superior…

2020 ASCO Virtual Direct™ Highlights

K. Kim

28 views
07:53

2020 ASCO Update on Advanced Melanoma: Does Adoptive TIL Therapy Hav…

2020 ASCO Virtual Direct™ Highlights

K. Kim

77 views
10:11

2020 ASCO Update on V600 BRAF Melanoma: Is the Combination of BRAF-T…

2020 ASCO Virtual Direct™ Highlights

K. Kim

86 views